[caption id="attachment_7675" align="alignright" width="207"] Gov. Bill Haslam[/caption]
On May 16, Tennessee Governor Bill Haslam signed a limited medical marijuana bill into law. SB 2531 proposes creating a four-year study on the benefits of cannabidiol, often referred to as “CBD,” a non-psychoactive component of marijuana. Unfortunately, the many limitations placed on the bill by lawmakers mean it is unlikely to result in relief for seriously ill patients in the state. MPP will not be counting Tennessee as a “medical marijuana state.”
The law unrealistically depends on the Drug Enforcement Administration authorizing the cultivation of marijuana within Tennessee for study. The DEA has maintained a monopoly on the cultivation of marijuana for research in Mississippi, and has steadfastly refused to allow other producers in the past 50 years. Even if it weren’t for that problem, laws that limit patient access to CBD leave most seriously ill patients behind. For a more detailed look at the bill and its many limitations, click here.
Under the bill, Vanderbilt University would conduct the study and Tennessee Tech would theoretically grow marijuana. As in Maryland, we hope Tennessee will move beyond its ineffective medical marijuana law and quickly pass a workable law that will help seriously ill patients in Tennessee.
Bill Haslam, CBD, DEA, Maryland, SB 2531, Tennessee, TN, Vanderbilt University
Even before the first medical marijuana ID card has been issued, both chambers of the Illinois General Assembly have voted to expand the state’s medical marijuana law to include more suffering patients. Earlier today, the House voted 98-18 to allow both adults and minors with seizure disorders to qualify for medical cannabis.
Illinois’ medical marijuana law, which was signed into law last August, is one of only three to leave behind seriously ill minors. The House amended SB 2636 to also allow the health department to develop rules allowing other seriously ill minors to qualify. The bill now heads to the Senate for concurrence.
[caption id="attachment_7655" align="alignright" width="214"] Sen. Diane Savino[/caption]
Today, the Senate Health Committee will vote on Sen. Diane Savino’s medical marijuana bill. This will be the first time since 2010 that a Senate committee has voted on the Compassionate Care Act, which has already been approved by the Assembly four times. If the bill passes the Senate Health Committee, it must pass at least one more committee vote before heading to the full Senate.
Thousands of New Yorkers continue to suffer needlessly because they cannot safely access medical marijuana, including children enduring hundreds of debilitating seizures daily. Get to know some of these children by watching this video produced by our allies at “NY Parents for Legalizing MMJ.”
The Compassionate Care Act would provide safe, legal access to medical marijuana for thousands of patients. An overwhelming 88% of New Yorkers support allowing medical marijuana.
Compassionate Care Act, Diane Savino, New York, NY, NY Parents for Legalizing MMJ, Quinnipiac, Senate Health Committee
The National Cannabis Industry Association is launching its first national conference, The Cannabis Business Summit, June 24-25 in Denver, Colorado. The summit will offer cannabis business leaders a national stage on which to discuss the best practices and business developments from around the industry. The summit will include more than 35 sessions, more than 800 attendees, and an exhibition floor featuring more than 30 leading cannabis businesses over the course of two days. Several topic-oriented tracks will give attendees the opportunity to focus on their areas of expertise. Conference highlights and topics covered will include:
Marijuana Policy Project Executive Director Rob Kampia will also be speaking at the event!
NCIA’s Cannabis Business Summit will be held at the Colorado Convention Center in downtown Denver. Along with the educational sessions and an exhibitor showcase, the event will also include a fundraising reception to support NCIA’s work advancing the policy goals of the responsible cannabis industry. Visit the conference website online, and register at http://www.cannabisbusinesssummit.com.
Colorado, Denver, National Cannabis Industry Association, NCIA
[caption id="attachment_7648" align="alignright" width="300"] Left, Michele Leonhart; right, Eric Holder[/caption]
In recent talks with Attorney General Eric Holder, DEA Chief Michele Leonhart was encouraged to tone down the Drug War propaganda she has been advancing since the Obama administration did not sue the state of Colorado for legalizing marijuana. Since then, she has taken several public stands against the administration’s rhetoric on marijuana legalization and, more recently, lessening the punishment of people who commit federal drug crimes.
According to Huffington Post’s Ryan Reilly and Ryan Grim, Leonhart was "called in" by Holder for a "one [on] one chat about her recent insubordination." As a 34-year bureaucrat of the DEA, Leonhart is having a hard time shifting her tone away from the DEA’s aggressive stance against illegal drugs.
Since the talks, Leonhart has said she “supports the Attorney General’s sentencing reform initiative to ensure those sentences are imposed appropriately” through legislation like the Smarter Sentencing Act. This type of legislation would save taxpayers billions of dollars and keep thousands of people out of jail for certain types of nonviolent crimes, like marijuana use, by eliminating mandatory minimum sentencing.
Michele Leonhart’s alignment with the Obama administration’s stance on drug sentencing and marijuana policy creates cautious optimism for change in the prosecution of unnecessary federal arrests.
attorney general, DEA, Eric Holder, insubordination, marijuana, Michele Leonhart, Smarter Sentencing Act
[caption id="attachment_7644" align="alignright" width="254"] Sen. Diane Savino[/caption]
New York Sen. Diane Savino (D-Staten Island) claims she has rallied enough votes to pass SB 4406, which legalizes medical marijuana. Thirty-nine senators, seven more than what is needed to pass the bill, have pledged their support.
However, gathering this support has come at a price. Three significant changes differentiate the current bill from the original.
First, physicians are limited to recommending medical marijuana for only 20 conditions. Secondly, the bill would create an advisory committee to recommend additions to the list of qualifying conditions. This board could also hear appeals for individual patients who fall outside of the list. Lastly, people under 21 would not be permitted to smoke marijuana as a treatment; they would be restricted to ingesting or vaporizing.
Other details of the bill include required medical marijuana cards for patients, a limit of up to 2.5 ounces per 30-day supply, and the dispensaries would have to pay taxes to the state.
According to the New York Daily News, it looks like the Senate’s Health Committee will take up the bill at noon on Tuesday.
bill, Diane Savino, marijuana, medical, New York, Pass, SB 4406, Senate, State
[caption id="attachment_7641" align="alignright" width="150"] Gov. Jay Nixon[/caption]
On Tuesday, Gov. Jay Nixon made Missouri history by allowing the state to join the ranks of 18 others that have eliminated the possibility of jail time for the possession of marijuana. The new law made several significant reforms to the state’s criminal laws, including protecting people caught with up to 10 grams from incarceration for choosing a substance that is safer than alcohol.
The governor decided not to sign SB 491, instead allowing it to become effective without his signature. In addition to “decriminalizing” simple possession of marijuana, this new law also reduces possible sentences related to the sale and cultivation of marijuana, including the current ban on probation or parole for those with 3rd felony offenses.
Unfortunately, the law is somewhat limited. It will not take effect until January 1, 2017, and the protections against jail time only apply to people without prior marijuana convictions. Also, a possession charge — even without the possibility of jail time — is still a crime and can mark a person for life, affecting housing, employment, and future employment opportunities.
Nonetheless, this represents several major improvements, and now statewide law is beginning to reflect those of both St. Louis and Columbia, which previously decriminalized possession of up to 35 grams of cannabis.
MPP wishes to thank Missouri attorney and activist Dan Viets and Show-Me Cannabis for their strong contributions to the new law!
Dan Viets, jail, Jay Nixon, Missouri, MO, possession, SB 491, Show Me Cannabis
[caption id="attachment_7638" align="alignright" width="128"] Sen. Lou Correa[/caption]
In California this week, SB 1262, introduced by Sen. Lou Correa, would create a long-overdue regulatory structure for medical cannabis cultivators and dispensaries, including collectives and cooperatives. The original bill draft contained many offensive provisions, including unreasonable and possibly unlawful requirements on physicians. Fortunately, Sen. Correa removed nearly all the troubling provisions and we now have a largely workable solution.
While medical marijuana patients have protections under state law, the citizens who serve them lack a regulatory framework. This leaves them vulnerable to aggressive federal law enforcement efforts to undermine the state program. In addition, regulation can help protect the environment, avoid unauthorized access, and reduce incidents of crime and violence. After the amendments were made, the bill passed out of committee with a unanimous vote, and will be heard next by the Senate Appropriations Committee.
Another bill died in committee. AB 2500 would have made everyone driving with 2 or more ng/mL of active THC in his or her system guilty of DUI. This unscientific and discriminatory bill failed to get sufficient votes to advance any further.
Both of these developments benefit medical cannabis patients in California!
AB 2500, CA, California, cultivators, dispensaries, Lou Correa, SB 1262
[caption id="attachment_7635" align="alignright" width="185"] Lydia Schaeffer[/caption]
Tragically, Lydia Schaeffer (aged 7) passed away on Mother’s Day from a rare genetic disorder called Kleefstra syndrome, which causes terrible seizures and other complications. Her plight inspired lawmakers in Wisconsin to legalize a marijuana extract to treat her condition, despite their opposition to a broader medical marijuana reform.
Sally Schaeffer, Lydia’s mother, lobbied the state legislature to legalize the cannabidiol (CBD) extract from the marijuana stain known as Charlotte’s Web for use on children with seizure disorders. Even though lawmakers moved to pass the limited CBD-only bill in record time, determining the implications of the law stalled it from going into effect. Additionally, CBD-only bills leave behind 98% of the patients who can benefit from medical marijuana, so Wisconsin still has a long way to go before patients have legal access to this much-needed medicine.
In Lydia's honor, Sally plans to continue spreading the word on CBD oil. She said she was contacted by Sen. Robert Wirch's office this week and told they would try to have the bill she championed called Lydia's Law. Wirch’s sympathy toward the Schaeffer family is welcomed, but his and other politicians’ compassion for the vast majority of other patients in need is currently lacking.
bill, cannabidiol, CBD, CharlotteÕs Web, Lydia Schaeffer, marijuana, medical, Robert Wirch, Sally Schaeffer, Wisconsin
An inside source told ESPN.com on Tuesday that the NFL is in the process of renegotiating its drug policy and may institute changes specific to how athletes who use marijuana are handled.
Since 2011, the NFL has been internally debating its drug policy, which includes testing for human growth hormones. If the current revisions to the drug policy are approved, the threshold for a positive marijuana test will be significantly increased, and punishments for violating the policy will be reduced.
The delay in these changes to the NFL policy stems from a “continued standoff over arbitration of discipline,” according to ESPN. “In cases of non-analytical positives (i.e., an Alex Rodriguez-type case in which a player is found to be in violation of the drug policy by some method other than a failed test) or in cases of violations of law (i.e., a player getting caught trying to smuggle prescription drugs across the Canadian border), the NFLPA has asked that discipline appeals be heard by an independent arbitrator.”
However, the NFL insists that the commissioner (Roger Goodell) has final say over disciplinary matters. Once this power struggle over the administration of discipline is resolved, the changes to the NFL’s drug policy should go into effect.